欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

美国镰状细胞贫血症治疗市场报告(2015-2019年)

Sickle-cell Anemia Therapeutics Market in the US 2015-2019

加工时间:2015-06-12 信息来源:EMIS 索取原文[51 页]
关键词:镰状细胞贫血症;不能;补偿;红细胞;过度损失;遗传性疾病
摘 要:Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to compensate for the excessive loss of erythrocytes, thereby leading to anemia. It is an inheritable disorder passed on across generations. The prevalence of the sickle-cell gene varies between different ethnic groups and geographical locations.
目 录:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offering

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Disease Overview

06. Introduction

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

15.1 Competitive Scenario

15.1.1 Key News

15.1.2 Mergers and Acquisitions

15.2 Pipeline Analysis

15.3 Market Share Analysis 2013

16. Future Prominent Vendors

17. Key Vendor Analysis

17.1 Bristol-Myers Squibb

17.1.1 Key Facts

17.1.2 Business Overview

17.1.3 Key Product Offerings

17.1.4 Revenue by Geography

17.1.5 Business Strategy

17.1.6 Key Information

17.1.7 SWOT Analysis

18. Other Reports in this Series

© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服